Caffeine and Postoperative Neurocognitive Recovery
咖啡因与术后神经认知恢复
基本信息
- 批准号:10517443
- 负责人:
- 金额:$ 57.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-02 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AcetylcholineAcuteAffectAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAnestheticsAreaArousalAwarenessBlindedBrainCaffeineCaringCharacteristicsClinicalClinical TrialsCognitionCognitiveConsumptionDataDeliriumDementiaDiagnosticDistressDoseElderlyFailureFamilyFoundationsFutureGoalsHealth ExpendituresHospitalizationHourImpaired cognitionIncidenceInterventionIntravenousLength of StayMeasuresMemoryNeurobiologyNeurocognitiveOperative Surgical ProceduresOutcomeParticipantPatientsPharmacologyPlacebo ControlPlacebosPostoperative PeriodProcessPublic HealthPurinergic P1 ReceptorsRandomizedRandomized Clinical TrialsRecoveryReportingResearchRiskScalp structureSeveritiesSubgroupSurgical complicationSyndromeSystemTechniquesTestingTherapeuticTimeWakefulnessarmbasecognitive functioncognitive testingdensitydesigneffective interventioneffective therapyexperiencefallsflexibilityfunctional declineimprovedinsightmeetingsmild cognitive impairmentmortalityneurocognitive disordernovelpostoperative deliriumpreventprimary outcomepublic health relevancerandomized placebo controlled trialrecruitrelating to nervous systemsecondary analysissecondary outcomewireless
项目摘要
TITLE: CAFFEINE AND POSTOPERATIVE NEUROCOGNITIVE RECOVERY
PROJECT SUMMARY
Delirium is a distressing clinical syndrome characterized by failure of basic cognitive functions that affects
approximately 20-50% of older surgical patients. Delirium during surgical recovery is associated with increased
mortality, increased healthcare expenditures, and future cognitive and functional decline. Moreover, there is
pathophysiologic overlap between delirium and Alzheimer’s Disease-Related Dementias; patients experiencing
delirium demonstrate increased risk of future dementia. Unfortunately, the underlying neurobiology of delirium
remains incompletely understood, and there are no biologically informed, effective therapies for preventing
postoperative delirium and related complications. Our preliminary data suggest that caffeine reduces delirium
in the postanesthesia care unit (PACU) after major surgery by shifting cortical dynamics towards neural
criticality. Criticality refers to a system state that is poised to dynamically fluctuate to meet demands. For
cognition, neural criticality is a potential mechanism by which functionally segregated areas of the brain can be
dynamically integrated over space and time to optimize cognition. In our preliminary trial, participants receiving
caffeine at the end of surgery demonstrated increased electroencephalographic (EEG) markers of criticality in
the PACU concurrent with delirium reduction. Nonetheless, the relationships among caffeine, neural criticality,
and postoperative neurocognitive recovery require additional, rigorous testing. Our long-term goal is to improve
neurobiological understanding of delirium and related neurocognitive disorders, such that effective therapies
can be developed. The objectives of this proposal are to (1) test an intervention for reducing early
postoperative delirium while (2) identifying dynamic brain changes that reflect cognitive vulnerability. The
central hypothesis is that caffeine will improve postoperative neurocognitive recovery in older adults. We will
test this hypothesis via a randomized, placebo-controlled, quadruple-blinded clinical trial. Aim 1 will determine
whether caffeine reduces the incidence of early postoperative delirium. Participants (n=250) will be randomized
to placebo, low-dose caffeine, or high-dose caffeine in a three-arm parallel design. A sequential randomization
design will also be used to test one vs. two days of caffeine therapy. Aim 2 will identify cortical dynamics
underlying early postoperative delirium. A wireless, high-density whole-scalp EEG system will enable the
analysis of neural criticality and the associations with caffeine and delirium. Lastly, Aim 3 will use the same
EEG system to test baseline neural criticality in trial participants meeting criteria for Mild Cognitive Impairment,
as deviations from criticality have been reported in patients with this condition as well as Alzheimer’s Disease.
Overall, the proposed research is significant because results may provide an effective, neurobiologically
informed intervention for reducing early postoperative delirium and related consequences. Additionally, results
will provide neurobiological insight into vulnerable cortical dynamics that portend delirium and, possibly,
subsequent neurocognitive disorders.
标题:咖啡因与术后神经认知恢复
项目总结
精神错乱是一种令人痛苦的临床综合征,其特征是基本认知功能的丧失,从而影响
大约20%-50%的老年外科患者。外科恢复期的精神错乱与
死亡率,增加的医疗费用,以及未来的认知和功能下降。此外,还有
精神错乱和阿尔茨海默病相关痴呆之间的病理生理学重叠:患者经历
精神错乱表明未来患痴呆症的风险增加。不幸的是,精神错乱的潜在神经生物学
仍然没有完全了解,也没有生物学上知情的有效治疗方法来预防
术后精神错乱及相关并发症。我们的初步数据显示咖啡因可以减少精神错乱。
在大手术后的感觉后护理病房(PACU),通过将皮质动力学转向神经
临界性。临界性是指系统状态随时准备动态波动以满足需求。为
认知,神经临界性是一种潜在的机制,通过它大脑的功能隔离区域可以
在空间和时间上动态整合以优化认知。在我们的初步试验中,参与者收到了
手术结束时咖啡因显示脑电(EEG)标志增加的危重
PACU伴随着神志不清的减少。尽管如此,咖啡因、神经临界性、
术后的神经认知恢复需要额外的、严格的测试。我们的长期目标是改进
对精神错乱和相关神经认知障碍的神经生物学了解,以便有效的治疗
可以被开发出来。这项建议的目标是(1)测试干预措施,以期及早减少
术后神志不清,同时(2)辨认反映认知脆弱性的动态脑变化。这个
中心假设是咖啡因将改善老年人术后的神经认知恢复。我们会
通过一项随机、安慰剂对照、四盲的临床试验来检验这一假设。目标一号将决定
咖啡因是否能降低术后早期精神错乱的发生率。参与者(n=250)将被随机分配
到安慰剂、低剂量咖啡因或高剂量咖啡因的三臂平行设计。顺序随机化
设计还将用于测试一天和两天的咖啡因治疗。目标2将确定大脑皮层动力学
术后早期精神错乱的潜在原因。无线、高密度全头皮脑电系统将使
神经临界性分析及其与咖啡因和精神错乱的关系。最后,《目标3》也将使用同样的方法
EEG系统用于测试符合轻度认知障碍标准的试验参与者的基线神经临界性,
据报道,在患有这种疾病和阿尔茨海默病的患者中,已经出现了偏离临界值的情况。
总体而言,拟议的研究具有重要意义,因为结果可能提供有效的、神经生物学的
减少术后早期精神错乱及相关后果的知情干预。此外,结果
将提供对脆弱的皮质动力学的神经生物学洞察,这些动力学预示着精神错乱,甚至可能,
随后的神经认知障碍。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Phillip Eleas Vlisides其他文献
Phillip Eleas Vlisides的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Phillip Eleas Vlisides', 18)}}的其他基金
Caffeine and Postoperative Neurocognitive Recovery
咖啡因与术后神经认知恢复
- 批准号:
10674966 - 财政年份:2022
- 资助金额:
$ 57.37万 - 项目类别:
Neurocognitive Recovery following Surgery and General Anesthesia
手术和全身麻醉后的神经认知恢复
- 批准号:
10218208 - 财政年份:2018
- 资助金额:
$ 57.37万 - 项目类别:
Neurocognitive Recovery following Surgery and General Anesthesia
手术和全身麻醉后的神经认知恢复
- 批准号:
9979648 - 财政年份:2018
- 资助金额:
$ 57.37万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 57.37万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 57.37万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 57.37万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 57.37万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 57.37万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 57.37万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 57.37万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 57.37万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 57.37万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 57.37万 - 项目类别:
Operating Grants